Research ReportsPI Industries Q1 Results Review - Higher Pharma Loss Dents CSM Beat: Nirmal Bang
ADVERTISEMENT
PI Industries Q1 Results Review - Higher Pharma Loss Dents CSM Beat: Nirmal Bang
The brokerage maintains its Accumulate rating on the company on account of a muted risk-reward and have raised its SOTP-based target price by 19.9% to Rs 4,406.
A scientist testing a chemical solution inside a research laboratory. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.